blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4308174

EP4308174 - METHODS AND MATERIALS FOR TREATING PROPIONIC ACIDEMIA [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  22.12.2023
Database last updated on 14.09.2024
FormerThe international publication has been made
Status updated on  23.09.2022
Most recent event   Tooltip24.05.2024Change: Validation statespublished on 26.06.2024  [2024/26]
24.05.2024Change - extension statespublished on 26.06.2024  [2024/26]
Applicant(s)For all designated states
Mayo Foundation for Medical Education and Research
200 First Street S.W.
Rochester, Minnesota 55905 / US
[2024/04]
Inventor(s)01 / BARRY, Michael, A.
Rochester, Minnesota 55901-7421 / US
 [2024/04]
Representative(s)Fish & Richardson P.C.
Highlight Business Towers
Mies-van-der-Rohe-Straße 8
80807 München / DE
[2024/04]
Application number, filing date22772309.518.03.2022
[2024/04]
WO2022US21003
Priority number, dateUS202163163198P19.03.2021         Original published format: US 202163163198 P
[2024/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022198079
Date:22.09.2022
Language:EN
[2022/38]
Type: A1 Application with search report 
No.:EP4308174
Date:24.01.2024
Language:EN
The application published by WIPO in one of the EPO official languages on 22.09.2022 takes the place of the publication of the European patent application.
[2024/04]
Search report(s)International search report - published on:US22.09.2022
ClassificationIPC:A61K48/00, C12N9/00, C12N15/864
[2024/04]
CPC:
C12N9/00 (EP); C12N15/86 (EP,US); A61K48/005 (EP);
A61K48/0058 (EP,US); A61P3/00 (US); C07K14/47 (US);
C12N9/93 (US); A01K2217/075 (EP); A01K2227/105 (EP);
A01K2267/0306 (EP); C12N2750/14143 (EP,US); C12N2830/008 (EP,US);
C12Y604/01003 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/04]
TitleGerman:VERFAHREN UND MATERIALIEN ZUR BEHANDLUNG VON PROPIONISCHER AZIDÄMIE[2024/04]
English:METHODS AND MATERIALS FOR TREATING PROPIONIC ACIDEMIA[2024/04]
French:MÉTHODES ET MATÉRIAUX POUR LE TRAITEMENT DE L'ACIDÉMIE PROPIONIQUE[2024/04]
Entry into regional phase18.10.2023National basic fee paid 
18.10.2023Search fee paid 
18.10.2023Designation fee(s) paid 
18.10.2023Examination fee paid 
Examination procedure18.10.2023Examination requested  [2024/04]
09.04.2024Amendment by applicant (claims and/or description)
Fees paidRenewal fee
18.10.2023Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]US2018140688  (KRAUS JAN P [US]);
 [XY]WO2020072451  (ULTRAGENYX PHARMACEUTICAL INC [US]);
 [XY]US2021077553  (HORDEAUX JULIETTE [US], et al);
 [PX]WO2021067598  (ULTRAGENYX PHARMACEUTICAL INC [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.